폐기능 검사 시스템 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Pulmonary Function Testing Systems Market size is expected to reach USD 6.71 Billion in 2034 from USD 3.63 Billion (2025) growing at a CAGR of 7.07% during 2026-2034.

The global pulmonary function testing systems market has grown steadily due to the rising prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease, and lung infections. Healthcare providers increasingly rely on pulmonary function tests to assess lung capacity, airflow, and overall respiratory health. Technological advancements in diagnostic equipment and the integration of digital monitoring tools have improved the accuracy and efficiency of these systems. Growing awareness about early disease detection and increasing healthcare infrastructure investments have also supported the market's expansion.

Several key drivers are fueling the growth of this market. The increasing incidence of smoking-related lung disorders and the growing geriatric population have created greater demand for respiratory diagnostics. Hospitals and diagnostic laboratories are adopting advanced testing systems that offer automated data analysis and portable testing capabilities. In addition, rising air pollution levels and occupational exposure to harmful particles have increased the need for routine respiratory health assessments, further encouraging the adoption of pulmonary function testing equipment.

Looking ahead, the market is expected to experience continued growth driven by innovation and expanding healthcare access. Portable and home-based pulmonary testing devices are likely to gain popularity as remote patient monitoring becomes more common. Integration with digital health platforms and artificial intelligence may enhance diagnostic accuracy and patient management. Emerging economies are expected to offer significant opportunities as healthcare systems modernize and governments invest more heavily in respiratory disease screening and preventive care.

MARKET SEGMENTATION

By Product

• Handheld
• Tabletop

By Test Type

• Spirometry
• Exercise Stress Test
• Lung Volume Test
• High Altitude Simulation Testing
• Gas Diffusion Test
• Other Test Types

By Application

• Chronic Obstructive Pulmonary Disease
• Asthma
• Chronic Shortness of Breath
• Pulmonary Fibrosis
• Other Applications

By End Use

• Hospitals & Clinics
• Diagnostic Centers
• Homecare Settings
• Other End Users

COMPANIES PROFILED

• Baxter International Inc, Chest MI Inc, COSMED Srl, ECO Medics AG, Fukuda Sangyo Co Ltd, Ganshorn Medizin Electronic GmbH Schiller Group, Geratherm Respiratory GmbH, Medical Equipment Europe GmbH, MGC Diagnostics Corporation, Minato Medical Science Co Ltd, Morgan Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Handheld Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Tabletop Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Spirometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Exercise Stress Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Lung Volume Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. High Altitude Simulation Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Gas Diffusion Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Test Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Chronic Obstructive Pulmonary Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Chronic Shortness of Breath Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Pulmonary Fibrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Homecare Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Test Type
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Test Type
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Test Type
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Test Type
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Test Type
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PULMONARY FUNCTION TESTING SYSTEMS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Baxter International Inc
  • 10.2.2 Chest M.I. Inc
  • 10.2.3 COSMED Srl
  • 10.2.4 ECO Medics AG
  • 10.2.5 Fukuda Sangyo Co. Ltd
  • 10.2.6 Ganshorn Medizin Electronic GmbH (Schiller Group)
  • 10.2.7 Geratherm Respiratory GmbH
  • 10.2.8 Medical Equipment Europe GmbH
  • 10.2.9 MGC Diagnostics Corporation
  • 10.2.10 Minato Medical Science Co. Ltd
  • 10.2.11 Morgan Scientific Inc